Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Détails

ID Serval
serval:BIB_F3804F73BCD6
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Périodique
Annals of oncology
Auteur(s)
Haanen JBAG, Carbonnel F., Robert C., Kerr K.M., Peters S., Larkin J., Jordan K.
Collaborateur(s)
ESMO Guidelines Committee
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
01/07/2017
Peer-reviewed
Oui
Volume
28
Numéro
suppl_4
Pages
iv119-iv142
Langue
anglais
Notes
Publication types: Journal Article ; Practice Guideline
Publication Status: ppublish
Mots-clé
Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Antineoplastic Agents, Immunological/adverse effects, Drug-Related Side Effects and Adverse Reactions/diagnosis, Drug-Related Side Effects and Adverse Reactions/etiology, Drug-Related Side Effects and Adverse Reactions/immunology, Drug-Related Side Effects and Adverse Reactions/therapy, Follow-Up Studies, Humans, Ipilimumab/adverse effects, Medical Oncology/standards, Neoplasms/drug therapy, Neoplasms/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/09/2017 15:28
Dernière modification de la notice
20/08/2019 17:20
Données d'usage